Assessment in mice of vapA-DNA vaccination against Rhodococcus equi infection.

The study examines the potential for creating a vapA-DNA vaccine that would instigate an immune response against the Rhodococcus equi infection, common in foals. The results indicate that the vaccine did indeed enhance the mice’s immune responses and was even further optimized when paired with a IL-12 gene injection.

Research Methodology

• The study primarily involved using the vapA protein from Rhodococcus equi, a bacteria known to cause pneumonia in foals. This protein was encoded into a DNA vaccine using pcDNA3.1, creating what is called a vapA-DNA vaccine.
• Two types of mice, C57BL/6 and BALB/c, were used as the test subjects. They were given the vapA-DNA vaccine via intramuscular injection.
• The researchers also tested a combination of this vaccine with pORF-IL-12, a plasmid that expresses murine IL12, to observe its effect on immunity.

Research Findings

• The researchers found that the administration of the vapA-DNA vaccine resulted in enhanced clearance of R. equi from the mice’s liver. The researchers assessed this by observing the liver after the mice were intravenously exposed to the bacteria.
• The immune response was found to be more robust when the vaccine was combined with the pORF-IL-12 plasmid, suggesting that the expression of IL-12 was instrumental in enhancing immune response against the infection.
• The production of antibodies against the VapA protein was increased in the immunized mice. Notably, the response of IgG2a, an immunoglobulin subtype, was more evident in mice given the pcDNA-vapA vaccine than those given either no immunization or the mixed vapA and IL-12 construct.

Conclusion

• The study establishes that the vapA-DNA vaccine can enhance the immune response of mice against Rhodococcus equi, signifying it has a potential for further development and possibly application in preventing this particular infection.
• The findings also suggest that co-administration of an IL-12 gene along with a vaccine could improve the overall immune response.
• The IgG subisotype response observed indicates that the response is aligned with a type 1-based immune response, which is essential for protection against the Rhodococcus equi infection.